Abstract
Antibody- and cell-mediated responses to sulfamethoxazole (SMX) were analyzed in AIDS patients with or without a history of hypersensitivity and in negative controls. In 20 of 20 (P < 0.01) human immunodeficiency virus (HIV)-seropositive patients with skin reactions to cotrimoxazole, we found SMX-specific antibodies, while only 9 of 20 and 17 of 20 HIV-seropositive patients without a history of hypersensitivity to cotrimoxazole had SMX-specific immunoglobulin M (IgM) and IgG, respectively. The levels of specific IgM and IgG were higher in patients with skin reactions than in patients without reactions (IgM, 1.0 +/- 0.19 versus 0.47 +/- 0.23 [P < 0.001]; IgG, 0.68 +/- 0.15 versus 0.47 +/- 0.14 [P < 0.001] [mean optical density values +/- standard deviations]). Seronegative controls with no history of exposure to sulfa compounds did not have SMX-specific IgG or IgM antibodies, and controls with a history of intake of SMX with or without reactions had low levels of IgG and IgM. The SMX-specific IgG subclasses were exclusively IgG1 and IgG3. None of the patients had detectable SMX-specific IgE or IgA antibodies nor did they exhibit a cell-mediated response as measured by a lymphocyte proliferation assay. Antibodies to SMX recognized N-acetyl-sulfonamide, N-(2-thiazolyl)-sulfanilamide, sulfadiazine, and sulfisoxazole but did not recognize sulfanilamide or 3-amino-5-methyl isoxazole in an inhibition assay. It is not known whether the SMX-specific antibodies associated with hypersensitivity reactions to SMX in HIV-seropositive patients have a pathogenic role in these reactions. Sulfanilamide or 3-amino-5-methyl isoxazole, on the other hand, could be potential alternative therapies in HIV-seropositive patients with a history of skin reactions to SMX.
Full Text
The Full Text of this article is available as a PDF (247.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carr A., Swanson C., Penny R., Cooper D. A. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis. 1993 Jan;167(1):180–185. doi: 10.1093/infdis/167.1.180. [DOI] [PubMed] [Google Scholar]
- Carr A., Tindall B., Penny R., Cooper D. A. In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV. Clin Exp Immunol. 1993 Oct;94(1):21–25. doi: 10.1111/j.1365-2249.1993.tb05971.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gordin F. M., Simon G. L., Wofsy C. B., Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1984 Apr;100(4):495–499. doi: 10.7326/0003-4819-100-4-495. [DOI] [PubMed] [Google Scholar]
- Gruchalla R. S., Sullivan T. J. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine. J Allergy Clin Immunol. 1991 Nov;88(5):784–792. doi: 10.1016/0091-6749(91)90186-r. [DOI] [PubMed] [Google Scholar]
- Jansson M., Wahren B., Scarlatti G., Principi N., Lombardi V., Livadiotti S., Elia L., Plebani A., Wigzell H., Rossi P. Patterns of immunoglobulin G subclass reactivity to HIV-1 envelope peptides in children born to HIV-1-infected mothers. AIDS. 1992 Apr;6(4):365–371. doi: 10.1097/00002030-199204000-00002. [DOI] [PubMed] [Google Scholar]
- Karpatkin S., Nardi M., Lennette E. T., Byrne B., Poiesz B. Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9763–9767. doi: 10.1073/pnas.85.24.9763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lambin P., Gervais A., Levy M., Defendini E., Dubarry M., Lebon P., Rouger P., Schuller E. Intrathecal synthesis of IgG subclasses in multiple sclerosis and in acquired immunodeficiency syndrome (AIDS). J Neuroimmunol. 1991 Dec;35(1-3):179–189. doi: 10.1016/0165-5728(91)90172-4. [DOI] [PubMed] [Google Scholar]
- Lee B. L., Medina I., Benowitz N. L., Jacob P., 3rd, Wofsy C. B., Mills J., 5th Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. Ann Intern Med. 1989 Apr 15;110(8):606–611. doi: 10.7326/0003-4819-110-8-606. [DOI] [PubMed] [Google Scholar]
- Papadea C., Check I. J. Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects. Crit Rev Clin Lab Sci. 1989;27(1):27–58. doi: 10.3109/10408368909106589. [DOI] [PubMed] [Google Scholar]
- Roy R., Tropper F. D., Romanowska A. New strategy in glycopolymer synthesis. Preparation of antigenic water-soluble poly(acrylamide-co-p-acrylamidophenyl beta-lactoside). Bioconjug Chem. 1992 May-Jun;3(3):256–261. doi: 10.1021/bc00015a009. [DOI] [PubMed] [Google Scholar]
- Shear N. H., Spielberg S. P., Grant D. M., Tang B. K., Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med. 1986 Aug;105(2):179–184. doi: 10.7326/0003-4819-105-2-179. [DOI] [PubMed] [Google Scholar]
- Tatake J. G., Knapp M. M., Ressler C. Synthesis and characterization of protein and polylysine conjugates of sulfamethoxazole and sulfanilic acid for investigation of sulfonamide drug allergy. Bioconjug Chem. 1991 Mar-Apr;2(2):124–132. doi: 10.1021/bc00008a008. [DOI] [PubMed] [Google Scholar]
- Uetrecht J. Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions. Crit Rev Toxicol. 1990;20(4):213–235. doi: 10.3109/10408449009089863. [DOI] [PubMed] [Google Scholar]
- van der Ven A. J., Koopmans P. P., Vree T. B., van der Meer J. W. Adverse reactions to co-trimoxazole in HIV infection. Lancet. 1991 Aug 17;338(8764):431–433. doi: 10.1016/0140-6736(91)91046-w. [DOI] [PubMed] [Google Scholar]